Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin
January 08, 2013 at 04:02 AM EST
Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB ) is 20.71%. Trinity Biotech's revenue for the same period is $81.70 million. The trailing-twelve-month profit margin at Meridian Bioscience (NASDAQ: VIVO ) is 19.23%.